未登录

R

Rasmus Mortensen

Statens Serum Institut

H指数:17

被引数:1,016

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Expression of CD103 facilitates localization and activation of CD4+ T cells within Mycobacterium tuberculosis lung-lesions

Mucosal Immunology

IF7.6

2026-02-030

OAAI

Intraperitoneal administration of cationic liposomes containing a TLR3 agonist recruits type I conventional dendritic cells and primes a local CD8+ T cell response

腹腔内给予含有TLR3激动剂的阳离子脂质体可招募I型经典树突状细胞，并引发局部的CD8+ T细胞反应

IF3.5

2025-11-270

OAAI

T cell-macrophage interactions in tuberculosis: What we've got here is failure to communicate

结核病中T细胞-巨噬细胞相互作用：我们在这里遇到的是沟通失败

JOURNAL OF INTERNAL MEDICINE

IF9.2

2025-11-010

OAAI

MINCLE and TLR9 agonists synergize to induce Th1/Th17 vaccine memory and mucosal recall in mice and non-human primates

NATURE COMMUNICATIONS

IF15.7

2024-10-170

OAAI

Cyclooxygenase inhibitors impair CD4 T cell immunity and exacerbate Mycobacterium tuberculosis infection in aerosol-challenged mice (vol 2, 288, 2019)

COMMUNICATIONS BIOLOGY

IF5.1

2024-05-290

OAAI

Repeated immunization with ATRA-containing liposomal adjuvant transdifferentiates Th17 cells to a Tr1-like phenotype

JOURNAL OF AUTOIMMUNITY

IF7

2024-04-010

OA

Whole blood RNA signatures in tuberculosis patients receiving H56:IC31 vaccine as adjunctive therapy

FRONTIERS IN IMMUNOLOGY

IF5.9

2024-02-161

OAAI

Co-adjuvanting DDA/TDB liposomes with a TLR7 agonist allows for IgG2a/c class-switching in the absence of Th1 cells (vol 8, 189, 2023)

IF6.5

2024-01-110

OAAI

Co-adjuvanting DDA/TDB liposomes with a TLR7 agonist allows for IgG2a/c class-switching in the absence of Th1 cells

IF6.5

2023-12-226

OAAI

A protective, single-visit TB vaccination regimen by co-administration of a subunit vaccine with BCG

IF6.5

2023-05-098

OAAI

Reduced vitamin D-induced cathelicidin production and killing of Mycobacterium tuberculosis in macrophages from a patient with a non-functional vitamin D receptor: A case report

FRONTIERS IN IMMUNOLOGY

IF5.9

2022-11-032

OAAI

A Phase I/II randomized trial of H56:IC31 vaccination and adjunctive cyclooxygenase-2-inhibitor treatment in tuberculosis patients

NATURE COMMUNICATIONS

IF15.7

2021-11-2246

OAAI

A Mycobacterium tuberculosis-specific subunit vaccine that provides synergistic immunity upon co-administration with Bacillus Calmette-Guerin

NATURE COMMUNICATIONS

IF15.7

2021-11-1845

OAAI

In Vivo Antigen Expression Regulates CD4 T Cell Differentiation and Vaccine Efficacy against Mycobacterium tuberculosis Infection

IF4.7

2021-04-278

OAAI

Rescuing ESAT-6 Specific CD4 T Cells From Terminal Differentiation Is Critical for Long-Term Control of Murine Mtb Infection

FRONTIERS IN IMMUNOLOGY

IF5.9

2020-11-0618

OAAI

Monocytic myeloid-derived suppressor cells reflect tuberculosis severity and are influenced by cyclooxygenase-2 inhibitors

JOURNAL OF LEUKOCYTE BIOLOGY

IF3.1

2020-11-0611

OAAI

Immunization with Mycobacterium tuberculosis-Specific Antigens Bypasses T Cell Differentiation from Prior Bacillus Calmette-Guerin Vaccination and Improves Protection in Mice

JOURNAL OF IMMUNOLOGY

IF3.4

2020-10-1515

OAAI

Cyclooxygenase inhibitors impair CD4 T cell immunity and exacerbate Mycobacterium tuberculosis infection in aerosol-challenged mice

环氧合酶抑制剂损害CD4 T细胞免疫并加剧气溶胶攻击小鼠的结核分枝杆菌感染

COMMUNICATIONS BIOLOGY

IF5.1

2019-08-0527

OAAI

Mucosal boosting of H56:CAF01 immunization promotes lung-localized T cells and an accelerated pulmonary response to Mycobacterium tuberculosis infection without enhancing vaccine protection

H56:CAF01预防接种的粘膜增强促进肺定位的T细胞和对结核分枝杆菌感染的加速肺部反应，而不增强疫苗保护

MUCOSAL IMMUNOLOGY

IF7.6

2019-05-0136

OAAI

KLRG1-Expressing CD4 T Cells Are Reduced in Tuberculosis Patients Compared to Healthy Mycobacterium tuberculosis-Infected Subjects, but Increase With Treatment

JOURNAL OF INFECTIOUS DISEASES

IF4.5

2019-03-194

PREAI